GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (LTS:0O9B) » Definitions » Interest Coverage

Almirall (LTS:0O9B) Interest Coverage : 0.13 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Almirall Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Almirall's Operating Income for the three months ended in Sep. 2024 was €1.0 Mil. Almirall's Interest Expense for the three months ended in Sep. 2024 was €-7.3 Mil. Almirall's interest coverage for the quarter that ended in Sep. 2024 was 0.13. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Almirall's Interest Coverage or its related term are showing as below:

LTS:0O9B' s Interest Coverage Range Over the Past 10 Years
Min: 0.71   Med: 9.27   Max: 4631.95
Current: 4.8


LTS:0O9B's Interest Coverage is ranked worse than
70.45% of 660 companies
in the Drug Manufacturers industry
Industry Median: 13.625 vs LTS:0O9B: 4.80

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Almirall Interest Coverage Historical Data

The historical data trend for Almirall's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Almirall Interest Coverage Chart

Almirall Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 165.98 9.95 8.58 12.89 6.31

Almirall Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 - - 28.42 0.13

Competitive Comparison of Almirall's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Almirall's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Almirall's Interest Coverage falls into.



Almirall Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Almirall's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Almirall's Interest Expense was €-7.2 Mil. Its Operating Income was €45.5 Mil. And its Long-Term Debt & Capital Lease Obligation was €386.0 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2023 )/Interest Expense (A: Dec. 2023 )
=-1*45.497/-7.208
=6.31

Almirall's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Here, for the three months ended in Sep. 2024, Almirall's Interest Expense was €-7.3 Mil. Its Operating Income was €1.0 Mil. And its Long-Term Debt & Capital Lease Obligation was €346.7 Mil.

Interest Coverage=-1* Operating Income (Q: Sep. 2024 )/Interest Expense (Q: Sep. 2024 )
=-1*0.966/-7.283
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Almirall  (LTS:0O9B) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Almirall Interest Coverage Related Terms

Thank you for viewing the detailed overview of Almirall's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Almirall Business Description

Traded in Other Exchanges
Address
Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall Headlines

No Headlines